English to Russian Medical Medical: Pharmaceuticals

Protocols must specify how any new therapy introduced before progression will affect best response designation.
The patient’s best overall response assignment will depend on the findings of both target and nontarget disease and will also take into consideration the appearance of new lesions.
Furthermore, depending on the nature of the trial and the protocol requirements, it may also require confirmatory measurement.